| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP1379250A2 A method of treating cancer |
| 01/14/2004 | EP1379140A2 Production of pancreatic islet cells and delivery of insulin |
| 01/14/2004 | EP1379134A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 01/14/2004 | EP1379126A1 Novel endophytic fungi and methods of use |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP1133359B1 Ultrathin-walled multiwell plate for heat block thermocycling |
| 01/14/2004 | EP0977889B1 Uses of calculus |
| 01/14/2004 | EP0975761B1 Recombinant human beta interferon with enhanced solubility |
| 01/14/2004 | EP0942758B1 Compounds with improved inductive effect on cartilage and bones |
| 01/14/2004 | EP0832229B1 Cd40l mutein |
| 01/14/2004 | EP0723598B1 Methods and compositions for efficient nucleic acid sequencing |
| 01/14/2004 | EP0636174B1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides |
| 01/14/2004 | CN1468317A Use of multiple recombination sites with unique specificity in recombinational cloning |
| 01/14/2004 | CN1468313A Novel constructs and their use in metabolic pathway engineering |
| 01/14/2004 | CN1468312A Chimeric gfp-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 01/14/2004 | CN1468311A Isomaltulose synthase |
| 01/14/2004 | CN1468310A Method for constructing cell strain of expression mutation type human tissue plasmin activator and preparation method of expressing protein |
| 01/14/2004 | CN1468309A Anti-il-12 antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468306A Schizophrenia related gene and protein |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468304A Method of producing functional protein domains |
| 01/14/2004 | CN1468302A Gsk3 polypeptides |
| 01/14/2004 | CN1468301A Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1468251A Specificity double-chain probe for average-phase detecting nucleic acid and method for implementing the same |
| 01/14/2004 | CN1468250A Production of humanized antibodies in transgenic animals |
| 01/14/2004 | CN1468124A Method and composition for altering a t cell mediated pathology |
| 01/14/2004 | CN1468123A Method and composition for altering a b cell mediated pathology |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467500A Immunoassay, reagent for immunoassay, and production method of the same |
| 01/14/2004 | CN1467297A Technology for detecting foot and mouth disease virus antibody of sick livestock using recombination foot and mouth disease vaccine gene expressing protein |
| 01/14/2004 | CN1467295A Method for producing blood vessel diseases gene medicine-blood vessel endothelium growth gene-2 naked DNA by microorganism cloning vehicle |
| 01/14/2004 | CN1467294A Multiplex pcr primer set for human glucokinase gene amplification |
| 01/14/2004 | CN1467293A Infectious bursal disease virus (IBDV) polyprotein gene (VP2/VP4/VP3), eukaryon expressing plasmid, DNA vaccine |
| 01/14/2004 | CN1467292A Highly effective expressing method of interleukin-12 |
| 01/14/2004 | CN1467291A Avian interleukin-2 (IL-2) gene and eukaryon expressing plasmid and immunity reinforcing agent of bird vaccine |
| 01/14/2004 | CN1467288A Ziqu mould Yunnan variety Ym3221 |
| 01/14/2004 | CN1467224A Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 01/14/2004 | CN1467223A Recombinated anti-CD25 monoclonal antibody, coding sequence and application |
| 01/14/2004 | CN1467222A Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line |
| 01/14/2004 | CN1134666C Method and reagent used for detecting virus of hepatitis C |
| 01/14/2004 | CN1134542C Transgenic plants expressing DNA constructs containing plurality of genes to impart virus resistance |
| 01/14/2004 | CN1134541C Use of tomato E8-derived promoters to express heterologous genes, E.G. 5-adenosylmethionine hydrolase, in ripening fruit |
| 01/14/2004 | CN1134540C Mosaid insecticiding protein gene able to secrete its product to outside of cell |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/14/2004 | CN1134538C Fy7 polymerase |
| 01/14/2004 | CN1134537C Preparation of human primitive mesenchymal stem cell population |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/14/2004 | CN1134260C Method of treatment for lung diseases using antisense oligonucleotides |
| 01/13/2004 | US6678050 In-situ detection and analysis of methane in coal bed methane formations with spectrometers |
| 01/13/2004 | US6677506 DNA coding for a Mg2+/H+ or Zn2+/H+ exchanger and transgenic plants expressing same |
| 01/13/2004 | US6677505 Promoter inductible in plants, sequence incorporating same and resulting product |
| 01/13/2004 | US6677504 Drought resistant and disease resistant plants; for use in the generation of agricultural products |
| 01/13/2004 | US6677503 Sunflower anti-pathogene proteins and genes and their uses |
| 01/13/2004 | US6677501 P2X7 receptor-deficient mice and uses thereof |
| 01/13/2004 | US6677500 Ungulates expressing exogenous IGF-I in their milk |
| 01/13/2004 | US6677445 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 01/13/2004 | US6677443 Isolated nucleic acid encoding lepidopteran octopamine/ tyramine transporter having sodium-dependent transport activity which has affinity for dopamine and which is inhibited by octopamine and tyramine |
| 01/13/2004 | US6677442 Isolated nucleic acid molecule comprising nucleotide sequence encoding polypeptide having specified amino acid sequence |
| 01/13/2004 | US6677436 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| 01/13/2004 | US6677432 Osteogenic protein-1 mutant having at least one amino acid residue substitution, and having improved in vitro refolding properties in ph range of about 6.0-9.0 |
| 01/13/2004 | US6677428 Cdna with nucleotide sequence 1 and protein with amino acid sequence 2 |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677301 Epithelial cell proliferation stimulants; wound healing agents |
| 01/13/2004 | US6677299 Method to increase cerebral blood flow in amyloid angiopathy |
| 01/13/2004 | US6677155 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 01/13/2004 | US6677153 Antisense antibacterial method and composition |
| 01/13/2004 | US6677152 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 01/13/2004 | US6677151 Device and method for thermal cycling |
| 01/13/2004 | US6677148 Pesticidal proteins |
| 01/13/2004 | US6677145 Isolating a nucleotide sequence having specific sequence, constructing a vector consists of an isolated nucleotide sequence operably linked to a promoter, introducing the vector into host cell for expression of elongase enzyme |
| 01/13/2004 | US6677140 Nucleic acid amplification with DNA-dependent RNA polymerase activity of RNA replicases |
| 01/13/2004 | US6677139 Methods for production of proteins in host cells |
| 01/13/2004 | US6677138 Production of a multimeric protein by cell fusion method |
| 01/13/2004 | US6677136 Glucagon antagonist domain, preferably having very little or no glucagon agonist activity, yeast-based screening phage display, rna- peptide screening, etc. attached to a vehicle, e.g., an fc domain, peg or dextran |
| 01/13/2004 | US6677134 Generation of zeaxanthin by fermentation; obtain cells, transform with vector, express vector, incubate with farnesyl pyrophosphate, recover zeaxanthin |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6677126 Antibody for human translational regulator |
| 01/13/2004 | US6677124 Monoclonal antibody recognizing C-terminus of hBNP |
| 01/13/2004 | US6677121 Fixed address analysis of sequence tags |
| 01/13/2004 | US6677118 Incubating under stringent hybridization conditions with nucleic acid probe |
| 01/13/2004 | US6677117 Inducing cell differentiation |
| 01/13/2004 | US6677115 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 01/13/2004 | US6676985 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 01/13/2004 | US6676949 Two-step immunization procedure against Chlamydia infection |
| 01/13/2004 | US6676945 Induction immunology response |
| 01/13/2004 | US6676944 Vaccine containing a peroxiredoxin and/or a β-tubulin |
| 01/13/2004 | US6676941 For inhibiting angiogenesis and induce tumor regression; cancer therapy |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/13/2004 | US6676935 Transfection target cells; genetic engineering |
| 01/13/2004 | US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 01/13/2004 | CA2112811C Continuous cell line and vaccine against avian coccidia |
| 01/13/2004 | CA2000498C Osteogenic factors |
| 01/12/2004 | CA2432938A1 Method for producing a microarray |
| 01/12/2004 | CA2403235A1 Modulation of cytochrome p450 reductase activity |
| 01/08/2004 | WO2004003820A2 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |